Orchid Pharma Ltd

NSE: ORCHPHARMA · BSE: 524372 · Pharmaceuticals & Biotechnology · 30 announcements

Share price: ₹1,024.25
Market cap: ₹6,134 Cr
Revenue (annual): ₹811.3 Cr
Net profit (annual): ₹20.55 Cr
P/E (TTM): 707.7×Sector 47.4×
Promoter holding: 74.45%+4.61% QoQ
FII holding: 0.92%Current quarter

Reference market data from a third-party provider, updated daily. Not a valuation or a recommendation.

Announcement type

All Earnings Call 6 Financial Results 4 Other Announcement 3 Board Meeting Date 3 Merger & Restructuring 2 Management Change 2 Legal & Regulatory 2 Acquisition 2 New Order Win 1 Fund Raise 1 Capital Structure Change 1 Board Meeting Outcome 1 Annual Report 1 Annual General Meeting 1

Time

All time Last 1 week Last 1 month Last 2 months Last 3 months Last 6 months Last 1 year

1 announcement with these filters

7 Jul 2026 19:27 IST NSE

New Order WinAlfa Alert

Orchid Pharma Bags ₹169.1 Cr Order

Orchid Pharma signed a licensing deal with Russia's Pharmasyntez, unlocking a $178M opportunity. This 10-year pact for Exblifep® marks a major international expansion for the Indian pharma firm.

Value: ₹169.1 Cr
Execution: 10 years

Read the filing ↗